LivingGLP1
Study S002276

Glucagon-like Peptide-1 Receptor Agonist for Reduction of Myocardial Injury After Non-Cardiac Surgery

Registration

Registration
NCT06324461
Acronym
GLUMINS
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
RECRUITING
Enrollment
372
Start
2024-03-20
Primary completion
2028-12-31
Lead sponsor
The University of Hong Kong
Conditions
Myocardial Injury
Interventions
DRUG:Dulaglutide 0.75mg subcutaneous injection
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Proportion of patients with MINS [Within 72 hours after surgery]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.